Audit 366369

FY End
2024-12-31
Total Expended
$1.10M
Findings
0
Programs
1
Year: 2024 Accepted: 2025-09-16

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.103 Food and Drug Administration Research $1.10M Yes 0

Contacts

Name Title Type
V7MPK8TJVNJ5 Ethan Whitmore Auditee
2025541600 Lindsay Dean Auditor
No contacts on file

Notes to SEFA

The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal award activity of the Organization under programs of the Federal Government for the year ended December 31, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The Schedule presents only a selected portion of the operations of the Organization; accordingly, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Organization.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Organization has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance.
Grants administrative fee $ 311,825 Direct Federal grant revenue included in contributions total on Exhibit B 788,884 TOTAL FEDERAL REVENUE RECOGNIZED $ 1,100,709